Loading...
OTCM
AFFY
Market cap41kUSD
Dec 04, Last price  
0.00USD
1D
-21.43%
1Q
37.50%
Jan 2017
-98.28%
IPO
-100.00%
Name

Affymax Inc

Chart & Performance

D1W1MN
OTCM:AFFY chart
P/E
—
P/S
0.03
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
-66.78%
Revenues
1m
-98.55%
0103,000225,000151,00074,00011,726,00044,336,00082,851,000114,899,000112,521,00047,720,00094,370,0001,369,000
Net income
-14m
L-84.56%
-10,244,000-28,046,000-28,361,000-21,398,000-32,576,000-48,288,000-43,069,000-86,510,000-76,531,000-14,075,000-61,367,000-93,412,000-14,424,000
CFO
-67m
L+81.12%
2,279,000-19,949,000-24,765,00068,298,000-45,539,000-62,631,000-80,927,000-49,234,000-71,966,000-37,180,000-67,339,000
Dividend
Nov 28, 20140.05 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.
URL
http://www.affymax.com/
IPO date
Dec 15, 2006
Employees
2
Domiciled in
US
Incorporated in
US

Valuation

No data to show